Photoprotective effects of bucillamine against UV-induced damage in an SKH-1 hairless mouse model

Photochemistry and Photobiology

Volumn 84, Issue 2, 2008, Pages 477-483

  Anwar, Adil ^a   Gu, Mallikarjuna ^a   Brady, Sara ^a   Qamar, Lubna ^b   Behbakht, Kian ^b   Shellman, Yiqun G ^a   Agarwal, Rajesh ^a   Norris, David A ^a   Horwitz, Lawrence D ^a   Fujita, Mayumi ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BUCILLAMINE; CYSTEINE; DRUG DERIVATIVE; PROTEIN P53; RADIOPROTECTIVE AGENT;

ANIMAL; ANIMAL MODEL; ARTICLE; FEMALE; HAIRLESS MOUSE; METABOLISM; MOUSE; ULTRAVIOLET RADIATION;

ANIMALS; ANTIOXIDANTS; CYSTEINE; FEMALE; MICE; MICE, INBRED HRS; MODELS, ANIMAL; RADIATION-PROTECTIVE AGENTS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

MUS;

EID: 41049113502     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2007.00288.x     Document Type: Article

References (50)

1. Ananthaswamy, H. N. W. E. Pierceall (1990) Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem. Photobiol. 52, 1119 1136.
2. Johnson, T. M., O. M. Dolan, T. A. Hamilton, M. C. Lu, N. A. Swanson L. Lowe (1998) Clinical and histologic trends of melanoma. J. Am. Acad. Dermatol. 38, 681 686.
3. Miller, D. L. M. A. Weinstock (1994) Nonmelanoma skin cancer in the United States: Incidence. J. Am. Acad. Dermatol. 30, 774 778.
4. Urbach, F. (1991) Incidence of nonmelanoma skin cancer. Dermatol. Clin. 9, 751 755.
5. Mitchell, D. L., R. Greinert, F. R. de Gruijl, K. L. Guikers, E. W. Breitbart, M. Byrom, M. M. Gallmeier, M. G. Lowery B. Volkmer (1999) Effects of chronic low-dose ultraviolet B radiation on DNA damage and repair in mouse skin. Cancer Res. 59, 2875 2884.
6. Pathak, M. A. K. Stratton (1968) Free radicals in human skin before and after exposure to light. Arch. Biochem. Biophys. 123, 468 476.
7. Katiyar, S. K., F. Afaq, K. Azizuddin H. Mukhtar (2001) Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol. Appl. Pharmacol. 176, 110 117.
8. Herrling, T., K. Jung J. Fuchs (2006) Measurements of UV-generated free radicals/reactive oxygen species (ROS) in skin. Spectrochim. Acta A Mol. Biomol. Spectrosc. 63, 840 845.
9. Hancock, J. T., R. Desikan S. J. Neill (2001) Does the redox status of cytochrome C act as a fail-safe mechanism in the regulation of programmed cell death? Free Radic. Biol. Med. 31, 697 703.
10. Pourzand, C., R. D. Watkin, J. E. Brown R. M. Tyrrell (1999) Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: The role of ferritin. Proc. Natl Acad. Sci. USA 96, 6751 6756.
11. Vink, A. A., D. B. Yarosh M. L. Kripke (1996) Chromophore for UV-induced immunosuppression: DNA. Photochem. Photobiol. 63, 383 386.
12. Larsson, P., E. Andersson, U. Johansson, K. Ollinger I. Rosdahl (2005) Ultraviolet A and B affect human melanocytes and keratinocytes differently. A study of oxidative alterations and apoptosis. Exp. Dermatol. 14, 117 123.
13. Athar, M., K. P. An, X. Tang, K. D. Morel, A. L. Kim, L. Kopelovich D. R. Bickers (2004) Photoprotective effects of sulindac against ultraviolet B-induced phototoxicity in the skin of SKH-1 hairless mice. Toxicol. Appl. Pharmacol. 195, 370 378.
14. Sen, C. K. (2000) Cellular thiols and redox-regulated signal transduction. Curr. Top. Cell. Regul. 36, 1 30.
15. Nishimura, N., V. E. Reeve, H. Nishimura, M. Satoh C. Tohyama (2000) Cutaneous metallothionein induction by ultraviolet B irradiation in interleukin-6 null mice. J. Invest. Dermatol. 114, 343 348.
16. Kramer, M., C. Sachsenmaier, P. Herrlich H. J. Rahmsdorf (1993) UV irradiation-induced interleukin-1 and basic fibroblast growth factor synthesis and release mediate part of the UV response. J. Biol. Chem. 268, 6734 6741.
17. Balkwill, F. A. Mantovani (2001) Inflammation and cancer: Back to Virchow? Lancet 357, 539 545.
18. Dannenberg, A. J. K. Subbaramaiah (2003) Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise. Cancer Cell 4, 431 436.
19. Horwitz, L. D. (2003) Bucillamine: A potent thiol donor with multiple clinical applications. Cardiovasc. Drug Rev. 21, 77 90.
20. Dhanalakshmi, S., G. U. Mallikarjuna, R. P. Singh R. Agarwal (2004) Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis. Carcinogenesis 25, 1459 1465.
21. Horwitz, L. D. N. A. Sherman (2001) Bucillamine prevents myocardial reperfusion injury. J. Cardiovasc. Pharmacol. 38, 859 867.
22. Amersi, F., S. K. Nelson, X. D. Shen, H. Kato, J. Melinek, J. W. Kupiec-Weglinski, L. D. Horwitz, R. W. Busuttil M. A. Horwitz (2002) Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc. Natl Acad. Sci. USA 99, 8915 8920.
23. Stewart, Z. A. J. A. Pietenpol (2001) p53 Signaling and cell cycle checkpoints. Chem. Res. Toxicol. 14, 243 263.
24. Maki, C. G. P. M. Howley (1997) Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell. Biol. 17, 355 363.
25. Siegel, D., A. Anwar, S. L. Winski, J. K. Kepa, K. L. Zolman D. Ross (2001) Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol. Pharmacol. 59, 263 268.
26. Jaffe, D. R. G. T. Bowden (1986) Ionizing radiation as an initiator in the mouse two-stage model of skin tumor formation. Radiat. Res. 106, 156 165.
27. Jaffe, D. G. T. Bowden (1987) Ionizing radiation as an initiator: Effects of proliferation and promotion time on tumor incidence in mice. Cancer Res. 47, 6692 6696.
28. Liebler, D. C. J. A. Burr (2000) Effects of UV light and tumor promoters on endogenous vitamin E status in mouse skin. Carcinogenesis 21, 221 225.
29. Ouhtit, A., H. K. Muller, D. W. Davis, S. E. Ullrich, D. McConkey H. N. Ananthaswamy (2000) Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin. Am. J. Pathol. 156, 201 207.
30. Matsumura, Y. H. N. Ananthaswamy (2002) Short-term and long-term cellular and molecular events following UV irradiation of skin: Implications for molecular medicine. Expert. Rev. Mol. Med. 4, 1 22.
31. Matsumura, Y. H. N. Ananthaswamy (2004) Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol. 195, 298 308.
32. Halliwell, B., R. Aeschbach, J. Loliger O. I. Aruoma (1995) The characterization of antioxidants. Food Chem. Toxicol. 33, 601 617.
33. Kladna, A., H. Y. Aboul-Enein, I. Kruk, T. Michalska K. Lichszteld (2006) Anti-oxidant and pro-oxidant behaviour of bucillamine. Luminescence 21, 90 97.
34. Whitekus, M. J., N. Li, M. Zhang, M. Wang, M. A. Horwitz, S. K. Nelson, L. D. Horwitz, N. Brechun, D. Diaz-Sanchez A. E. Nel (2002) Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitization. J. Immunol. 168, 2560 2567.
35. Hiura, T. S., N. Li, R. Kaplan, M. Horwitz, J. C. Seagrave A. E. Nel (2000) The role of a mitochondrial pathway in the induction of apoptosis by chemicals extracted from diesel exhaust particles. J. Immunol. 165, 2703 2711.
36. Hikichi, T., F. Mori, M. Nakamura, N. Shishido, M. Sasaki, Y. Horikawa A. Yoshida (2002) Inhibitory effects of bucillamine on increased blood-retinal barrier permeability in streptozotocin-induced diabetic rats. Curr. Eye Res. 25, 1 7.
37. Mori, F., J. Takahashi, T. Nagaoka, T. Abiko, T. Hikichi A. Yoshida (2006) Inhibitory effect of bucillamine on the increased leukocyte entrapment in the retinal microcirculation of diabetic rats. Jpn. J. Ophthalmol. 50, 377 379.
38. Ceconi, C., S. Curello, A. Cargnoni, R. Ferrari, A. Albertini O. Visioli (1988) The role of glutathione status in the protection against ischaemic and reperfusion damage: Effects of N-acetyl cysteine. J. Mol. Cell. Cardiol. 20, 5 13.
39. De Flora, S., A. Izzotti, F. D'Agostini R. M. Balansky (2001) Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22, 999 1013.
40. Iwatani, M., E. Inoue, T. Nakamura, A. Nakajima, M. Hara, T. Tomatsu, N. Kamatani H. Yamanaka (2006) Efficacy profile of bucillamine in rheumatoid arthritis patients in a large observational cohort study, IORRA. Mod. Rheumatol. 16, 376 380.
41. Munakata, Y., S. Iwata, J. Dobers, T. Ishii, M. Nori, H. Tanaka C. Morimoto (2000) Novel in vitro effects of bucillamine: Inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells. Arthritis Rheum. 43, 1616 1623.
42. Schwarz, T. T. A. Luger (1989) Effect of UV irradiation on epidermal cell cytokine production. J. Photochem. Photobiol. B, Biol. 4, 1 13.
43. Dinarello, C. A. (1996) Biologic basis for interleukin-1 in disease. Blood 87, 2095 2147.
44. Maltzman, W. L. Czyzyk (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4, 1689 1694.
45. Fritsche, M., C. Haessler G. Brandner (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8, 307 318.
46. Shieh, S. Y., M. Ikeda, Y. Taya C. Prives (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325 334.
47. Unger, T., T. Juven-Gershon, E. Moallem, M. Berger, R. Vogt Sionov, G. Lozano, M. Oren Y. Haupt (1999) Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18, 1805 1814.
48. Cory, S. J. M. Adams (2002) The Bcl2 family: Regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2, 647 656.
49. Isozaki, T., M. Kimura, N. Ikegaya, T. Arai, Y. Fujigaki, A. Hishida E. Kaneko (1992) Bucillamine (a new therapeutic agent for rheumatoid arthritis) induced nephrotic syndrome: A report of two cases and review of the literature. Clin. Investig. 70, 1036 1042.
50. Yamamoto, T. H. Yokozeki (2007) Yellow nails under bucillamine therapy for rheumatoid arthritis: A report of two cases. Rheumatol. Int. 27, 603 604.